The kinetic analysis was determined by incubating substrate (5 μ m) with purified SNAPf protein (1 μ m) in reaction buffer (1 m m DTT, 1×PBS) at 22 °C and removing aliquots at 0, 0.55, 0.75 0.75, 1, 2, 4, 8, 16, 32, and 64 min. Labeling efficiency was evaluated using SDS-PAGE and in-gel fluorescence scanning.
Initial velocities for substrate turnover were determined by use of various substrate concentrations (0.1 4 m m) in reaction mixtures (0.8 mL) each containing an aliquot of enzyme (OYE2, final protein concentration 100 μg mL−1) in Tris ⋅HCl buffer solution (50 m m, pH 7.5) with NADH (15 m m).
Briefly, cells were permeabilised with digitonin (0.15 mg ml 1) and subsequently exposed to blunt-ended oligonucleotide (5′-CGGAATTCCG-3′ Invitrogen) at 200 μg ml 1 in the presence of excess NAD+ (7 m) in reaction buffer (100 m Tris-HCl, 120 m MgCl2, pH=7.8) for 6 min at 27 °C.
Owing to the low M KMnO4 in reaction, the color of S2 is lighter than S4.
Andreasen [46] reviewed the hydrogen storage properties of Al Mg alloys and reported that the Mg n Al m compound (in reaction (6)) has been found to be mainly the β-phase.
Vesicles in the supernatant were then sedimented through a layer of 0.5 ml 0.4 M sucrose in reaction buffer at 55000 rpm in a Beckman TLA55 rotor at 4°C.
m by n stoichiometric matrix of metabolite m in enzymatic reaction n.
Theoretically, any alkali and alkali-earth cations can be used as the alkali element (M) in the reaction; however, the majority of the research has focused on the effect of sodium (Na+) and potassium (K+) ions (Phair and van Deventer 2002; van Jaarsveld and van Deventer1999b).
A unit of enzymatic activity was defined as 1 μmol of substrate transformed min−1 per mg protein extract (Nicholson et al, 1995).The general caspase inhibitor Q-VD-OPh (R&D Systems, Oxfordshire, UK) was added at 10 μ M in the reaction as a control.
We used a constant concentration of ATP (200 μ m) in the reaction buffer but included increasing concentrations of the non-hydrolyzable ATP analogue adenosine 5′- β,γ-imido)triphosphate (AMP-PNP) which is a competitive inhibitor for ATP and therefore reduces the turnover number of the kinase.
